News|Articles|February 10, 2023
SCOPE 2023: Venture Capital in Clinical Research
Author(s)Andy Studna, Senior Editor
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures discusses how 2023 could be a year of resurgence for venture dollars in clinical research following some retrenchment in 2022.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
2
From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting
3
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
4
Why Time Savings Is the Largest Driver of RBQM's Financial Value
5